Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) caused by DENV are main fatalities, manifested by endothelial cell injury leading to plasma leakage, which is currently considered to be associated with multiple mechanisms, such as cellular autophagic antiviral response, release of inflammatory factors, and endothelial barrier protein deficiency (Ramirez et al., 2018; Cabezas et al., 2018). Cellular autophagy, an important pathway for maintaining the intracellular environment homeostasis, degrades intracellular harmful protein accumulations, senescent organelles, and harmful pathogenic microorganisms through lysosomes (Xie et al., 2021). Autophagy is important for innate and adaptive immunity against bacteria and viruses, and many studies have demonstrated the interaction between viral infection and various stages of autophagy, especially in the stages of autophagosome–lysosome fusion and lysosome degradation. Hepatitis C virus (HCV) inhibits lysosomes and lysosome fusion by increasing the expression level of Arl8b, blocking autophagy and lysosome degradation. Varicella-zoster virus (VZV) mediates the formation of autophagic vesicles, but the blocked late autophagic flux is associated with the defective autophagosome–lysosome fusion or degradation. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORF3a protein prevents the autophagosome–lysosome fusion, and the ORF7a protein decreases lysosomal acidity, thereby blocking autophagic degradation (Jones-Jamtgaard et al., 2019; Graybill et al., 2018; Koepke et al., 2021). DENV and autophagy have been found to be closely related, and most current studies suggest that DENV-induced autophagy facilitates viral replication, providing energy for viral replication through the degradation of lipids and proteins, while the formation of autophagic vesicles provides a site for replication (Richards and Jackson, 2013). It was found that DENV infection promoted autophagy in the early stages and may be inhibited in the late stages, blocking the autophagic flux by impeding the autophagosome–lysosome fusion. However, the molecular mechanism is not elucidated and it remains unclear how DENV affects the lysosomal degradation pathway in the subsequent stages of the intact autophagic response (Metz et al., 2015).
In this study, the formation of autophagic vesicles was observed by TEM, along with an increase in the LC3-II expression level, implying that DENV-2 induced the formation of autophagic vesicles; the level of p62 showed no significant change at the early stage of infection and increased significantly after 30 h. The difference in LC3 expression levels between the DNEV2-infected, CQ-treated, and DNEV2 combined with CQ-treated groups was not significant, but higher than the blank group, indicating that infection impaired the autophagic flux at the late stage, and the formation of autophagic vesicles did not depend on the autophagic flux change. It was shown that SNAREs series proteins STX17, SNAP29, and VAMP8 formed a complex to promote the autophagosome–lysosome fusion, and during the fusion process, STX17 first localized on the autophagosomal membrane and then recruited SNAP29 and VAMP8 to form a complex. The absence of one of the three proteins does not affect the formation of autophagosomes but hinders the fusion, thus causing the autophagic flux blockage (Shen et al., 2021; Lorincz and Juhasz, 2020). This study examined the changes in the expression levels of fusion key proteins STX17, SNAP29, and VAMP8 at the late stage of infection. STX17, a primary fusion key protein, showed a low expression level, and although the expression level showed an increasing trend over time, it was always lower than the uninfected group. The proteins, SNAP29 and VAMP8, were higher than the blank group at 24 h of infection, but both were lower than the uninfected group after 24 h. Furthermore, it was confirmed that blocking autophagosome–lysosome fusion and low expression of STX17, SNAP29, and VAMP8 in the late DENV infection were related. Additionally, the blocking fusion may be related to the infection time.
Normal lysosomal acidification is essential for the lysosomal degradation pathway, maintaining normal cell metabolism, growth, and contributing to the clearance of pathogenic microorganisms by autophagy. When the lysosomal function is dysfunctional, even if autophagosomes–lysosomes fuse normally, the substrates within autophagosomes are not degraded and provide more membrane structures for virus replication, allowing viruses localized on autophagosomal membranes to further inhibit the autophagosomal substrate degradation. The studies reporting that DENV-2 impedes the autophagosome–lysosome fusion shows an understudy of autophagic degradation (Metz et al., 2015). This study reported that DENV-2 impeded the autophagosome–lysosome fusion, affected by low expression levels of key fusion proteins. Furthermore, DENV-2 could interfere with the normal lysosomal acidification, thus negatively affecting lysosomal autophagic degradation and blocking the autophagic flux, increasing the intracellular autophagic vesicles in the process.
In summary, it was found that DENV-2 infection activated autophagy in HUVECs at an early stage, induced the autophagosome formation, promoted p62 accumulation at the late stage of infection, decreased the expression levels of STX17, SNAP29, and VAMP8 to hinder the autophagosome–lysosome fusion process, and interfered with the normal lysosomal acidification to inhibit lysosomal autophagic degradation and accelerated cell death. Although this study highlighted the effect of DENV-2 infection on the autophagic process of HUVECs, in-depth studies on the molecular mechanism of how DENV-2 infection interferes with the lysosomal acidification are still needed to provide strong evidence for the autophagic antiviral response.